Welcome to Symptoma

Symptoma is your digital health assistant.

It helps you understand what might be wrong if you are feeling unwell. Simply state your symptoms and answer questions to find possible medical causes.

Symptoma is based on 16 years of scientific research by medical doctors and data scientists to help patients find possible medical causes for their symptoms.

Today, Symptoma is the most used symptom checker among both, doctors and patients, with millions of users and searches per month. Its diagnostic accuracy is raising the bar in its industry and has been validated in internal, external, and peer-reviewed scientific publications comparing up to 107 solutions worldwide where Symptoma clearly ranked as #1.

app screenshot

Simply state your symptoms and answer questions to find possible medical causes for your symptoms.

Symptoma is the best & most promising eHealth solution
European Commission & Dutch Ministry of Health in 2016

Our founder, Jama Nateqi, was invited to speak in the European Parliament (in 2017) and in the German Bundestag (in 2019) about Symptoma and our mission.

jama nateqi eu

Who is Symptoma?

Each year, 1.5 million lives could be saved with the right diagnosis.
To err is human. But in medicine, errors cost lives. The delivery of health care has proceeded for decades with a blind spot: “Diagnostic errors - inaccurate or delayed diagnoses - persist throughout all settings of care and continue to harm an unacceptable number of patients.” - National Academy of Medicine
"Every patient deserves the right diagnosis and treatment"
16 years
research & development
36
product languages
34
research projects validating Symptoma
>20k
diseases and causes
3
offices
46
international awards won

Real-World evidence on differentiating COVID-19 symptoms

2022 - March

Symptoma’s study “Symptoms associated with a COVID-19 infection among a non-hospitalized cohort in Vienna” in cooperation with the City of Vienna has been published in The Central European Journal of Medicine.

Award for best cutting-edge research

2021 - September

Symptoma receives the Houska Award as Austrian company with the best cutting-edge research.

Image by Alexander Müller

European Parliament features Symptoma

2021 - April

The European Parliament features Symptoma as role-model technology against COVID-19.

Austrian Government awards Symptoma

2021 - March

The Austrian government presents Symptoma as the best digital COVID-19 solution from Austria to 40 governments during the United Nations meeting.

European Commission features Symptoma

2021 - March

The European Commission features Symptoma as key player in Europe’s recovery plan.

Austrian Federal Ministry awards Symptoma

2020 - December

The Austrian Federal Ministry for Digital and Economic Affairs awards Symptoma as Austrian Top Digital Innovation.

Image by Hartberger; Bundesministerium für Digitalisierung und Wirtschaftsstandort (BMDW)

Collaboration with Austrian medical publisher

2020 - November

The MedTrix Group (one of the biggest Austrian medical publishers) collaborates with Symptoma.

City of Vienna contracts Symptoma to help citizens

2020 - November

The City of Vienna deploys Symptoma to give guidance for Viennese citizens with COVID-19 like symptoms. Huge success with nationwide coverage and 1.5 million questions and answers processed within the first 24h.

Image by FSW

Highest accuracy confirmed by peer-reviewed study

2020 - October

JMIR releases Symptoma’s peer-reviewed study “Diagnostic Accuracy of Web-Based COVID-19 Symptom Checkers: Comparison Study” demonstrating that Symptoma’s accuracy among online tests for identifying the risk of COVID-19 for symptomatic patients is the highest on the global market.

COVID-19 study published by Nature

2020 - October

Nature publishes Symptoma’s study “An artificial intelligence based first line defence against COVID 19: digitally screening citizens for risks via a chatbot”, proving that Symptoma’s AI correctly assesses the risk of COVID-19 in 96.32% of symptomatic patients.

Our founder becomes the Austrian of the Year 2020

2020 - October

Our CEO and founder, Jama Nateqi, becomes the Austrian of the Year for his research at Symptoma.

Image by DiePresse/Fabry

Austrian Procurement Agency lists Symptoma’s solution

2020 - September

The Austrian Procurement Agency officially lists Symptoma on their website as COVID-19 solution next to PCR, Antigen, and Antibody tests.

Insurers and companies contract Symptoma to fight the pandemic

2020 - June

Symptoma supports insurers and companies like the UNIQA Insurance Group in realizing their return-to-office plan and coming back to work safely.

Austrian Government contracts Symptoma to fight the pandemic

2020 - May

The Austrian government contracts Symptoma to help fight the pandemic.

Relaunch as Medical Device Class I

2020 - May

Symptoma is officially relaunched as a Medical Device Class I per Council Directive 93/42/EEC.

Hospitals contract Symptoma to fight the pandemic

2020 - April

Hospitals like the private clinic Döbling rely on Symptoma’s COVID-19 risk assessment at the building entrance to protect their patients and visitors.

Image by PremiQaMed Group

Symptoma adds COVID-19 to main product

2020 - January

The Digital Health Assistant trains for the new disease COVID-19 leading to the first study results published in March 2020 demonstrating 96.32% accuracy in classifying the risk in symptomatic patients. Our first prototype at symptoma.com detects COVID-19 risk in symptomatic patients with 96.32% accuracy (96.66% sensitivity, 96.31% specificity, n = 1142 case reports).

Collaboration with biggest medical publisher in DACH

2019 - October

Major deal signed with the biggest medical publisher in DACH (Thieme) leading to the integration of Symptoma.com in Thieme’s digital world reaching +200k medical professionals and +3,000 institutions (e.g., hospitals) in DACH.

Highest diagnostic accuracy rates

2019 - May

Symptoma ranked #1 in publication of a peer-reviewed performance study.

German Society for Internal Medicine awards Symptoma

2019 - May

The German Society for Internal Medicine designated Symptoma the Lateral Thinker award.

Image by Sven Bratulic

European Commission doubles down on Symptoma

2018

The European Commission chose Symptoma among thousands of SMEs to solve the problem of misdiagnosis. Symptoma received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 830017.

Eurostars

2017 - November

European Commissions designated Symptoma for the first time as a Eurostars company. Symptoma validated its diagnostic algorithms in cardiology cases with European partners.

Speech in European Parliament

2017 - October

European Commission & EU budget commissioner, Guenther Oettinger, awarded Symptoma as Top 50 EU Company and invited our founder to speak in the European Parlament.

Export Champion

2016 – October

Government of Upper Austria awarded Symptoma as Export Champion.

Top 10 Health Innovation Worldwide

2016 – October

German minister of health, Hermann Gröhe, awarded Symptoma at the World Health Summit 2016.

Best & most promising eHealth solution

2016 - June

Awarded by the European Comission and the Dutch Ministry of Health.

TEDx Talk

2016 - June

The Blindspot in Medicine: Or How to Save 1.5 Million Lives.

Pitch in TV Show

2014

Symptoma’s pitch in Austria’s favorite startup TV became legendary when four of five investors made an offer right on stage.

Image by Joerg Klickermann

Pioneers Festival – Top 3

2013 - October

First public pitch. Outmatched more than 1000 startups worldwide. Ran out of business cards and Symptoma made the 3rd place.

Beta-Version of Symptoma released tailored at medical doctors.

2013

Validation study

2012

Standardized testing with hundreds of cases led by the University Hospital of Salzburg, Austria.

Proof of Concept

2009

First performance study conducted.

Alpha-Version of Symptoma

2008

First major deal won

2007

Expanding Symptoma’s R&D team within offices of the incubator “Business Creation Center Salzburg”.

Research & Development started on Symptoma

2006

The idea of Symptoma was born, and the R&D started. Both founders, Thomas Lutz and Jama Nateqi, built a team and committed to helping patients receiving their right diagnosis. With a long-standing track record as co-founders (since 2002) and as successful social entrepreneurs, they had already disrupted the German educational market reaching millions of students per month with a team-size of more than a hundred people.

Say hello to some of the people behind Symptoma